Selskabets formål er at drive virksomhed med at udvikle lægemidler samt dermed beslægtede aktiviteter og at være Holding virksomhed for selskaber med tilsvaren-de formål.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 0 | -11.9 mio. | 3.6 mio. | -8.8 mio. | - | |
CVR: 30082346
Secondary names: Heslet Pharma A/S, TRIFOILIUM A/S
Previous names: WYSPA ApS, TRIFOILIUM ApS, REPONEX PHARMACEUTICALS ApS
Compared to 131 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Christian Henrik Tange joined as ADM. DIR.
Sebastian Bo Jakobsen left as ADM. DIR.
BDO Statsautoriseret Revisionspartnerselskab appointed as auditor
BDO Holding VII, statsautoriseret revisionsaktieselskab resigned as auditor
Companies in the same industry and area
companydata.dk